Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J.
Leukosite, Inc., Cambridge, MA, United States
Search 4 grants from Michael Briskin
Search grants from Leukosite, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect
Transcriptional Regulation of Sterol 12-Alpha-Hydrolase
3D Finite Element Model of Human Cervical Spine Under Dynamic Impact Loading
Students in Health Professional Schools
Development of Screening Tests for Htlv-III
Recently added grants:
Cerebral arterial compliance, blood flow, and cognition in Veterans with diabetes
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD
Impact of Left Hemisphere Stroke on Cognitive Functioning and Implications for Driving
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
rTMS in alleviating Pain and Co-morbid symptoms in GWVI
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049883-02
Application #
2016997
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1995-06-15
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Leukosite, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1997
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
NIH 1996
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
Comments
Be the first to comment on Michael Briskin's grant